Kumar Suresh, PhD

Kumar Suresh, PhD, is a cell biologist and biochemist with more than twenty years of expertise in ubiquitin research. Dr. Suresh has a PhD from Indian Institute of Science, Bangalore, India. He was a postdoctoral fellow at the University of Pennsylvania, Philadelphia PA. Dr. Suresh has led Progenra’s discovery efforts including establishment of the UbiProTM drug discovery platform and several HTS campaigns that discovered novel small molecule modulators of E3 ligases and DUBs. In his current role as Vice President of R&D, Dr. Suresh manages drug discovery, medicinal chemistry, and development of drug candidates at Progenra. Dr Suresh has published over forty papers in scholarly journals. He is recognized as a leader in ubiquitin proteasome system, PROTACs and molecular glue drugs. Dr. Suresh led the discovery and preclinical development of Progenra’s Parkin and PINK1 activators and more recently he has been spearheading the lead development of PINK1 activators.